# HEZQARA Enterprise Roadmap — E9–E24

## Purpose

This document freezes the enterprise product sequence after the verified E8/post-E8 engineering foundation. A phase is not complete merely because a matching module or migration exists.

## Product thesis

Hezqara is a governed AI workforce for healthcare operations and clinical documentation. It operates around the EHR rather than replacing the EHR or the clinician.

Workforces → Agents → Capabilities → Workflows → Tools → Policies → Evidence

Clinical authority remains human. AI-generated clinical documentation is draft material until the authorized clinician reviews, edits where needed, and explicitly approves it.

## Frozen phase sequence

| Phase | Scope | Completion gate |
|---|---|---|
| E9 | Product & Architecture Finalization | Canonical product/domain/architecture contracts and evidence ledger established |
| E10 | Patient Access Workforce | Production-grade access, intake, scheduling and administrative workflows |
| E11 | Insurance & Authorization Workforce | Eligibility, benefits, authorization and referral workflows with governed payer boundaries |
| E12 | Revenue Cycle Workforce | Claims, A/R, denials, appeals and revenue-cycle automation |
| E13 | Patient Financial Workforce | Patient billing, payments, balances, financial communications and controls |
| E14 | Document, Fax & Referral Intelligence | Ingestion, classification, extraction, routing and evidence-backed referral/document workflows |
| E15 | Ambient Clinical Documentation / AI Scribe | Governed audio-to-draft-documentation workflow with clinician approval |
| E16 | Documentation Intelligence | Structured documentation extraction, quality, coding-support and longitudinal intelligence |
| E17 | Patient Engagement & Care-Gap Workforce | Governed outreach, recall and care-gap workflows |
| E18 | Unified Healthcare AI Workforce | Cross-workforce orchestration with shared policy, evidence and approval boundaries |
| E19 | Hezqara Command Center | Operational control plane for workforce, workflow, evidence, integrations and exceptions |
| E20 | AI Governance, MCP & Clinical Documentation Safety | Tool gateway, MCP boundary, model/provider controls, adversarial safety and documentation integrity |
| E21 | Interoperability & Provider Productionization | Real provider/EHR/payer integration contracts, credentials, conformance and production evidence |
| E22 | Enterprise Security & Compliance Readiness | Security, privacy, PHI, contractual and independent-assurance readiness |
| E23 | Reliability, Scale & Disaster Recovery | Capacity, resilience, backup/restore, DR, failover and operational scale evidence |
| E24 | Commercialization, Independent Validation & General Availability | Pilot evidence, unit economics, contracts, external validation and GA release gate |

## Rules

1. Do not skip or pre-complete later phases.
2. Later-phase prerequisites may be documented when necessary, but implementation remains in the owning phase.
3. Any change that invalidates an earlier phase reopens that phase's evidence gate.
4. MCP is an integration interface, not the authorization boundary.
5. Technical readiness is not regulatory certification, clinical efficacy, contractual readiness or production-scale proof.
6. Vercel production deployment remains prohibited until E24 and the final forensic audit are complete.

## Current baseline

E1–E8 and post-E8 forensic hardening are documented by the repository as verified engineering controls. The current implementation sequence therefore begins at E9.
